Casdin Capital as of June 30, 2018
Portfolio Holdings for Casdin Capital
Casdin Capital holds 32 positions in its portfolio as reported in the June 2018 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Foundation Medicine | 13.6 | $94M | 685k | 136.70 | |
Loxo Oncology | 9.6 | $66M | 380k | 173.48 | |
Blueprint Medicines (BPMC) | 6.0 | $41M | 645k | 63.50 | |
Sage Therapeutics (SAGE) | 5.7 | $39M | 250k | 156.53 | |
Myokardia | 5.6 | $39M | 780k | 49.65 | |
Spark Therapeutics | 5.6 | $38M | 463k | 82.76 | |
Bluebird Bio (BLUE) | 4.6 | $31M | 200k | 156.95 | |
Agios Pharmaceuticals (AGIO) | 4.5 | $31M | 365k | 84.23 | |
Fate Therapeutics (FATE) | 4.3 | $30M | 2.6M | 11.34 | |
Codexis (CDXS) | 4.2 | $29M | 2.0M | 14.40 | |
Alnylam Pharmaceuticals (ALNY) | 3.9 | $27M | 270k | 98.49 | |
Global Blood Therapeutics In | 3.5 | $24M | 530k | 45.20 | |
Voyager Therapeutics (VYGR) | 3.2 | $22M | 1.1M | 19.54 | |
GenMark Diagnostics | 3.2 | $22M | 3.4M | 6.38 | |
Illumina (ILMN) | 2.9 | $20M | 72k | 279.29 | |
Sangamo Biosciences (SGMO) | 2.9 | $20M | 1.4M | 14.20 | |
Audentes Therapeutics | 2.5 | $17M | 450k | 38.21 | |
Crispr Therapeutics (CRSP) | 1.9 | $13M | 220k | 58.76 | |
Evolent Health (EVH) | 1.7 | $12M | 550k | 21.05 | |
Beigene | 1.6 | $11M | 70k | 153.73 | |
OraSure Technologies (OSUR) | 1.5 | $11M | 640k | 16.47 | |
Clovis Oncology | 1.5 | $10M | 220k | 45.47 | |
Biolife Solutions (BLFS) | 1.2 | $8.3M | 1.0M | 8.33 | |
Editas Medicine (EDIT) | 0.9 | $6.4M | 178k | 35.83 | |
Magenta Therapeutics | 0.8 | $5.4M | 400k | 13.50 | |
Neogen Corporation (NEOG) | 0.8 | $5.2M | 65k | 80.18 | |
Cytomx Therapeutics (CTMX) | 0.7 | $4.7M | 208k | 22.86 | |
Zai Lab (ZLAB) | 0.5 | $3.1M | 135k | 23.25 | |
Jounce Therapeutics | 0.4 | $2.9M | 375k | 7.66 | |
Caredx (CDNA) | 0.4 | $2.4M | 200k | 12.24 | |
Homology Medicines | 0.3 | $2.3M | 115k | 20.40 | |
Neon Therapeutics | 0.1 | $945k | 75k | 12.60 |